External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ASRS 2021
Roche and Genentech at

ASRS 2021

October 08 - October 12
San Antonio, USA
asrs.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
10:10 AM
Duration 6mins Virtual
Efficacy, Safety, and Durability of Faricimab in Diabetic Macular Edema (DME): One-Year Results From the Phase 3 YOSEMITE and RHINE Trials
Baumal CR, Willis JR, Haskova Z, Adamis AP, Ives J, Abreu F, Basu K, Lin H
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:00 AM
Duration 6mins Virtual
To characterize central subfield thickness (CST) fluctuations and their potential impact on vision outcomes in the Archway trial of the Port Delivery System with ranibizumab (PDS)
Jhaveri C, Blotner S, Gune S
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:06 AM
Duration 4mins Virtual
Analysis of Retinal Fluid and Vision Outcomes in the Archway Phase 3 Trial of the Port Delivery System With Ranibizumab (PDS) in Patients With nAMD
Khanani A, Blotner S, Gune S, Morral M
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:10 AM
Duration 6mins Virtual
Faricimab in Neovascular Age-Related Macular Degeneration: Week 48 Efficacy, Safety, and Durability Results From the Phase 3 TENAYA and LUCERNE Trials
Csaky K, Quezada-Ruiz C, Ives J, Basu K, Silverman D
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:04 AM
Duration 4mins Virtual
Key Pearls of Conjunctival and Tenon’s Capsule Handling During the Implant Insertion Procedure for the Port Delivery System With Ranibizumab (PDS)
Sheth V, Menezes A, Malhotra V
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:08 AM
Duration 4mins Virtual
Key Pearls of the Refill-Exchange Procedure for the Port Delivery System with Ranibizumab (PDS)
Graff J, Singh N, Barteselli G, Callaway N, Malhotra V, Menezes A
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:10 AM
Duration 6mins Virtual
Updated Safety and Efficacy Results From the Archway Phase 3 Trial of the Port Delivery System With Ranibizumab (PDS) for Neovascular AMD
Awh C, Barteselli G, Fung AE, Kardatzke D, Makadia S, Morral M, Willis J, Gune S
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:16 AM
Duration 4mins Virtual
Pharmacokinetic Profile of the Port Delivery System With Ranibizumab in the Phase 3 Archway Trial
Kitchens J, Gune S, Maia M, Ding HT, Kaagedal M, Maass K
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:30 AM
Duration 6mins Virtual
Long-term Experience With Intravitreal Anti-VEGF in Patients With nAMD: Analysis of Intelligent Research in Sight (IRIS®) Registry Database
Leng T, Garmo V, Neuberger E, Fevrier H, LaPrise A, Wykoff C
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:48 AM
Duration 4mins Virtual
Treatment Patterns and Visual and Health Function in Neovascular Age-Related Macular Degeneration (nAMD): Medicare Current Beneficiary Survey Analysis
Ali F, Khanani A, Garmo V,Abbass I, Menezes A, Ng C, Zhao X, Banerji T, Wada K, Near A, Oderda G, Brixner D, Biskupiak J
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:01 AM
Duration 4mins Virtual
Intravitreal Anti-VEGF Therapy in Maintaining Long-term Driving Vision in Diabetic Macular Edema and Neovascular Age-related Macular Degeneration
Emami-Naeini P, Boucher N, Fernando R, Menezes A, Garmo V
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.